Neogen Co. (NASDAQ:NEOG) Shares Acquired by Diversified Trust Co

Diversified Trust Co increased its stake in Neogen Co. (NASDAQ:NEOG) by 25.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,629 shares of the company’s stock after acquiring an additional 9,707 shares during the period. Diversified Trust Co’s holdings in Neogen were worth $752,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. raised its holdings in shares of Neogen by 5.8% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 12,900 shares of the company’s stock valued at $259,000 after purchasing an additional 711 shares in the last quarter. Sheets Smith Wealth Management raised its stake in Neogen by 2.6% in the fourth quarter. Sheets Smith Wealth Management now owns 30,795 shares of the company’s stock valued at $619,000 after buying an additional 771 shares in the last quarter. Northwest Investment Counselors LLC lifted its holdings in Neogen by 1.1% during the 1st quarter. Northwest Investment Counselors LLC now owns 71,621 shares of the company’s stock worth $1,130,000 after buying an additional 809 shares during the last quarter. Retirement Systems of Alabama lifted its holdings in Neogen by 0.3% during the 4th quarter. Retirement Systems of Alabama now owns 246,534 shares of the company’s stock worth $4,958,000 after buying an additional 827 shares during the last quarter. Finally, Lazard Asset Management LLC boosted its position in shares of Neogen by 0.6% during the 3rd quarter. Lazard Asset Management LLC now owns 142,586 shares of the company’s stock worth $2,643,000 after acquiring an additional 893 shares in the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Neogen Trading Up 0.6 %

NASDAQ NEOG opened at $15.13 on Wednesday. Neogen Co. has a 12 month low of $11.46 and a 12 month high of $24.09. The company has a market capitalization of $3.28 billion, a price-to-earnings ratio of 1,513.00 and a beta of 1.19. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.82 and a quick ratio of 2.66. The firm’s fifty day moving average price is $14.29 and its 200 day moving average price is $15.72.

Neogen (NASDAQ:NEOG) last posted its earnings results on Tuesday, April 9th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.02). The firm had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. Neogen had a return on equity of 3.35% and a net margin of 0.17%. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.12 EPS. On average, sell-side analysts expect that Neogen Co. will post 0.46 earnings per share for the current fiscal year.

Insider Buying and Selling at Neogen

In other Neogen news, Director James C. Borel bought 7,500 shares of the stock in a transaction dated Thursday, April 11th. The shares were acquired at an average cost of $13.06 per share, for a total transaction of $97,950.00. Following the completion of the transaction, the director now owns 21,392 shares in the company, valued at approximately $279,379.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, COO Douglas Edward Jones acquired 10,000 shares of Neogen stock in a transaction on Wednesday, April 17th. The stock was purchased at an average cost of $12.36 per share, with a total value of $123,600.00. Following the purchase, the chief operating officer now directly owns 46,131 shares in the company, valued at $570,179.16. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director James C. Borel bought 7,500 shares of the stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $13.06 per share, for a total transaction of $97,950.00. Following the completion of the purchase, the director now directly owns 21,392 shares in the company, valued at approximately $279,379.52. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 53,000 shares of company stock worth $662,205. 0.71% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, Piper Sandler decreased their target price on Neogen from $19.00 to $17.00 and set a “neutral” rating for the company in a research note on Monday, April 15th.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.